Adenosine Receptor Modeling: What Does the A2A Crystal Structure Tell Us?

被引:37
作者
Dal Ben, D. [1 ]
Lambertucci, C. [1 ]
Marucci, G. [1 ]
Volpini, R. [1 ]
Cristalli, G. [1 ]
机构
[1] Univ Camerino, Sch Pharm, Med Chem Unit, I-62032 Camerino, MC, Italy
关键词
Adenosine receptors; docking; homology modeling; molecular modeling; mutagenesis; structure-based drug design; PROTEIN-COUPLED RECEPTORS; SITE-DIRECTED MUTAGENESIS; HUMAN A(3)-ADENOSINE RECEPTOR; LIGAND-BINDING-SITE; MOLECULAR-DYNAMICS SIMULATION; HUMAN A(1)-ADENOSINE RECEPTOR; HUMAN A(3); ANTAGONIST BINDING; DRUG DESIGN; PHARMACOLOGICAL EVALUATION;
D O I
10.2174/156802610791293145
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
For a long time, there have been no experimentally determined structural data for any adenosine receptor (AR) and the only approach available for making structure/function correlations about these proteins has been homology modeling. While the early attempts to model these receptors followed the crystallization of bacteriorhodopsin, the cryo-microscopy studies of bovine and frog rhodopsin, and the modeling of a C alpha-template for the TM helices in the rhodopsin family of GPCRs, the crystallization of bovine rhodopsin by Palczewski was of extreme importance as it first provided the crystal structure of an eukaryotic GPCR to be used as template for more realistic homology models. Since then, rhodopsin-based modeling became the routine approach to develop AR structural models that proved to be useful for interpretation of site-directed mutagenesis data and for molecular docking studies. The recently reported crystal structures of the adrenergic beta1 and beta2 receptors only partially confirmed the structural features showed by bovine rhodopsin, raising a question about which template would have been better for further modeling of ARs. Such question remained actually not-answered, due to the publication in late 2008 of the crystal structure of human adenosine A(2A) receptor (AA(2A)R). Since its publication, this structure has been used for ligands docking analysis and has provided a high similarity template for homology modeling of the other AR subtypes. Still, the AA2AR crystal structure allows to verify the hypotheses that were made on the basis of the previously reported homology modeling and molecular docking.
引用
收藏
页码:993 / 1018
页数:26
相关论文
共 177 条
[1]   Structure-activity relationships of 2,N6,5′-substituted adenosine derivatives with potent activity at the A2B adenosine receptor [J].
Adachi, Hayamitsu ;
Palaniappan, Krishnan K. ;
Ivanov, Andrei A. ;
Bergman, Nathaniel ;
Gao, Zhan-Guo ;
Jacobson, Kenneth A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (08) :1810-1827
[2]   Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors? [J].
Archer, E ;
Maigret, B ;
Escrieut, C ;
Pradayrol, L ;
Fourmy, D .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (01) :36-40
[3]  
ASKALAN R, 1994, J NEUROCHEM, V63, P1477
[4]   THE PROBABLE ARRANGEMENT OF THE HELICES IN G-PROTEIN-COUPLED RECEPTORS [J].
BALDWIN, JM .
EMBO JOURNAL, 1993, 12 (04) :1693-1703
[5]  
Ballesteros J. A., 1995, Neuroscience Methods, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471]
[6]   Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A3 adenosine receptor antagonists [J].
Baraldi, PG ;
Cacciari, B ;
Moro, S ;
Spalluto, G ;
Pastorin, G ;
Da Ros, T ;
Klotz, KN ;
Varani, K ;
Gessi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :770-780
[7]   Fluorosulfonyl- and bis-(β-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives:: Irreversible antagonists at the human A3 adenosine receptor and molecular modeling studies [J].
Baraldi, PG ;
Cacciari, B ;
Moro, S ;
Romagnoli, R ;
Ji, XD ;
Jacobson, KA ;
Gessi, S ;
Borea, PA ;
Spalluto, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (17) :2735-2742
[8]   Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists [J].
Baraldi, Pier Giovanni ;
Preti, Delia ;
Tabrizi, Mojgan Aghazadeh ;
Romagnoli, Romeo ;
Saponaro, Giulia ;
Baraldi, Stefania ;
Botta, Maurizio ;
Bernardini, Cesare ;
Tafi, Andrea ;
Tuccinardi, Tiziano ;
Martinelli, Adriano ;
Varani, Katia ;
Borea, Pier Andrea .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (24) :10281-10294
[9]  
Barbhaiya H, 1996, MOL PHARMACOL, V50, P1635
[10]  
Becker OM, 2003, CURR OPIN DRUG DISC, V6, P353